SPIRONOLACTONE TEVA 25 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

SPIRONOLACTONE

Available from:

TEVA ISRAEL LTD

ATC code:

C03DA01

Pharmaceutical form:

TABLETS

Composition:

SPIRONOLACTONE 25 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TEVA ISRAEL LTD, ISRAEL

Therapeutic area:

SPIRONOLACTONE

Therapeutic indications:

Edematous conditions: - congestive heart failure; - cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. Essential hypertention. Primary hyperaldostronism. Hypokalemia.

Authorization date:

2021-11-30

Patient Information leaflet

PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor's prescription only
SPIRONOLACTONE TEVA
25 MG
SPIRONOLACTONE TEVA
100 MG
TABLETS
TABLETS
COMPOSITION:
COMPOSITION:
Each tablet contains:
Each tablet contains:
Spironolactone 25 mg
Spironolactone 100 mg
For information about inactive ingredients see section 6 -
“Additional information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine.
If you have additional questions, refer to the doctor or the
pharmacist.
This medicine has been prescribed for your treatment. Do
not pass it on to others. It may harm them even if it seems to
you that their medical condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Treatment
of
congestive
heart
failure,
cirrhosis
of
the
liver accompanied by edema and ascites, lowering blood
pressure, adrenal gland overactivity (hyperaldosteronism),
hypokalemia (low levels of potassium in the blood).
THERAPEUTIC CLASS:
Spironolactone belongs to a group of medicines called
potassium-sparing diuretics.
2. BEFORE USING THE MEDICINE
Do not use this medicine if:
•
You are sensitive (allergic) to the active ingredient or to
any of the other ingredients this medicine contains (see
section 6 – “additional information”).
•
You suffer from urinary retention.
•
You suffer from a severe kidney disease.
•
You
suffer
from
Addison’s
disease
(a
disease
characterized by a feeling of exhaustion, loss of weight
and low blood pressure).
•
You suffer from hyperkalemia (excess potassium in the
blood).
•
You are breastfeeding.
•
You are taking potassium-sparing diuretics or potassium
supplements.
•
You are taking a medicine that contains the active
ingredient
eplerenone
(administered
to
treat
heart
failure).
•
Do not use the medicine in children suffering from
moderate to severe kidney disease.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
BEFORE TREATMENT WITH SPIRONOLACTONE TEV